Activating Compound | Comment | Organism | Structure |
---|---|---|---|
Calmodulin | - |
Homo sapiens | |
tetrahydrobiopterin | - |
Homo sapiens |
Application | Comment | Organism |
---|---|---|
medicine | no evidence for altered enzyme function of mutant E298D that could explain endothelial dysfunction associated with the E298D polymorphism | Homo sapiens |
Protein Variants | Comment | Organism |
---|---|---|
E298D | comparable to wild-type in heme and flavin content, in affinity to calmodulin and dimerization | Homo sapiens |
KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|
0.0044 | - |
L-arginine | wild-type | Homo sapiens | |
0.0052 | - |
L-arginine | mutant E298D | Homo sapiens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
expression in Pichia pastoris | - |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
endothelium | - |
Homo sapiens | - |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
0.142 | - |
wild-type | Homo sapiens |
0.159 | - |
mutant E298D | Homo sapiens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
2 L-arginine + 3 NADPH + 4 O2 + 3 H+ | - |
Homo sapiens | 2 L-citrulline + 2 NO + 3 NADP+ + 4 H2O | - |
? |